» Articles » PMID: 15964600

Effects of Emodin Treatment on Mitochondrial ATP Generation Capacity and Antioxidant Components As Well As Susceptibility to Ischemia-reperfusion Injury in Rat Hearts: Single Versus Multiple Doses and Gender Difference

Overview
Journal Life Sci
Publisher Elsevier
Date 2005 Jun 21
PMID 15964600
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Effects of emodin (EMD) treatment on mitochondrial ATP generation capacity and antioxidant components as well as susceptibility to ischemia-reperfusion (I-R) injury were examined in male and female rat hearts. Isolated-perfused hearts prepared from female rats were less susceptible to I-R injury than those of male rats. I-R caused significant decreases in ATP generation capacity and reduced glutathione (GSH) and alpha-tocopherol (alpha-TOC) levels as well as glutathione reductase, Se-glutathione peroxidase and Mn-superoxide dismutase (SOD) activities. The lower susceptibility of female hearts to myocardial I-R injury was associated with higher levels of GSH and alpha-TOC as well as activity of SOD than those of male hearts. EMD treatment at 3 daily doses (0.6 or 1.2 mmol/kg) could enhance myocardial mitochondrial ATP generation capacity and antioxidant components in both male and female rat hearts, but it only significantly protected against I-R injury in female hearts. Treatment with a single dose of EMD invariably enhanced mitochondrial antioxidant components and protected against I-R injury in both male and female hearts. The gender-dependent effect of EMD treatment at multiple doses may be related to the differential antioxidant response in the myocardium and/or induction of drug metabolizing enzymes in the liver.

Citing Articles

Mitochondria and myocardial ischemia/reperfusion injury: Effects of Chinese herbal medicine and the underlying mechanisms.

Zhang C, Chang X, Zhao D, He Y, Dong G, Gao L J Pharm Anal. 2025; 15(2):101051.

PMID: 39931135 PMC: 11808734. DOI: 10.1016/j.jpha.2024.101051.


Effects of Fermented on the Skeletal Muscle Functions.

Kim Y, Han J, Lim C, Fang X, Jang H, Lee S Nutrients. 2024; 16(2).

PMID: 38276543 PMC: 10818974. DOI: 10.3390/nu16020305.


Emodin in cardiovascular disease: The role and therapeutic potential.

Guo Y, Zhang R, Li W Front Pharmacol. 2023; 13:1070567.

PMID: 36618923 PMC: 9816479. DOI: 10.3389/fphar.2022.1070567.


Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug.

Li Q, Gao J, Pang X, Chen A, Wang Y Front Pharmacol. 2020; 11:559607.

PMID: 32973538 PMC: 7481471. DOI: 10.3389/fphar.2020.559607.


Anticancer potential of emodin.

Hsu S, Chung J Biomedicine (Taipei). 2020; 2(3):108-116.

PMID: 32289000 PMC: 7104001. DOI: 10.1016/j.biomed.2012.03.003.